Striatal dopamine transporter (DAT) expresses in the presynaptic axonal terminals of nigrostriatal pathways, so that striatal DAT has been proposed as a biomarker of nigral DA neuronal loss in PD. This evidence concerns the gene SLC6A3 and Parkinson disease.